BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35180692)

  • 1. Integrated microfluidic system for isolating exosome and analyzing protein marker PD-L1.
    Lu Y; Ye L; Jian X; Yang D; Zhang H; Tong Z; Wu Z; Shi N; Han Y; Mao H
    Biosens Bioelectron; 2022 May; 204():113879. PubMed ID: 35180692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized detection of circling exosomal PD-L1 based on Fe
    Pang Y; Shi J; Yang X; Wang C; Sun Z; Xiao R
    Biosens Bioelectron; 2020 Jan; 148():111800. PubMed ID: 31678824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of exosomal PD-L1 in tumor progression and immunotherapy.
    Xie F; Xu M; Lu J; Mao L; Wang S
    Mol Cancer; 2019 Oct; 18(1):146. PubMed ID: 31647023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence Super-Resolution Imaging Chip for Gene Silencing Exosomes.
    Yin G; Qi T; Wei J; Wang T; Wang Z; Cui Y; Zong S
    Sensors (Basel); 2023 Dec; 24(1):. PubMed ID: 38203034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients.
    Wang J; Zhang H; Sun X; Wang X; Ren T; Huang Y; Zhang R; Zheng B; Guo W
    J Nanobiotechnology; 2020 Oct; 18(1):151. PubMed ID: 33092576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of circulating exosomes and identification of exosomal PD-L1 for predicting immunotherapy response.
    Zhang J; Zhu Y; Guan M; Liu Y; Lv M; Zhang C; Zhang H; Zhang Z
    Nanoscale; 2022 Jun; 14(25):8995-9003. PubMed ID: 35700522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoplasmonic Sandwich Immunoassay for Tumor-Derived Exosome Detection and Exosomal PD-L1 Profiling.
    Wang C; Huang CH; Gao Z; Shen J; He J; MacLachlan A; Ma C; Chang Y; Yang W; Cai Y; Lou Y; Dai S; Chen W; Li F; Chen P
    ACS Sens; 2021 Sep; 6(9):3308-3319. PubMed ID: 34494426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy.
    Ayala-Mar S; Donoso-Quezada J; González-Valdez J
    J Immunol Res; 2021; 2021():8839978. PubMed ID: 33628854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic-based exosome isolation and highly sensitive aptamer exosome membrane protein detection for lung cancer diagnosis.
    Zhao L; Wang H; Fu J; Wu X; Liang XY; Liu XY; Wu X; Cao LL; Xu ZY; Dong M
    Biosens Bioelectron; 2022 Oct; 214():114487. PubMed ID: 35780540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-color fluorescence co-localization of PD-L1-overexpressing cancer exosomes.
    Wei J; Zhu K; Chen Z; Yang Z; Yang K; Wang Z; Zong S; Cui Y
    Mikrochim Acta; 2022 Apr; 189(5):182. PubMed ID: 35394232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer.
    Lux A; Kahlert C; Grützmann R; Pilarsky C
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coaxial dual-path electrochemical biosensing and logic strategy-based detection of lung cancer-derived exosomal PD-L1.
    Liu J; Liu Z; Zhao C; Jiao Y; Li B; Shi J; Chen Z; Zhang Z
    Nanoscale; 2024 May; 16(18):8950-8959. PubMed ID: 38630023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer.
    Tang Y; Zhang P; Wang Y; Wang J; Su M; Wang Y; Zhou L; Zhou J; Xiong W; Zeng Z; Zhou Y; Nie S; Liao Q
    Front Immunol; 2020; 11():604. PubMed ID: 32322256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate and rapid quantification of PD-L1 positive exosomes by a triple-helix molecular probe.
    Fan Z; Weng Q; Li Y; Zeng T; Wang J; Zhang H; Yu H; Dong Y; Zhao X; Li J
    Anal Chim Acta; 2023 Apr; 1251():340984. PubMed ID: 36925282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
    Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bimodal liquid biopsy for cancer immunotherapy based on peptide engineering and nanoscale analysis.
    Bu J; Jeong WJ; Jafari R; Kubiatowicz LJ; Nair A; Poellmann MJ; Hong RS; Liu EW; Owen RH; Rawding PA; Hopkins CM; Kim D; George DJ; Armstrong AJ; Král P; Wang AZ; Bruce J; Zhang T; Kimple RJ; Hong S
    Biosens Bioelectron; 2022 Oct; 213():114445. PubMed ID: 35679646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracing Tumor-Derived Exosomal PD-L1 by Dual-Aptamer Activated Proximity-Induced Droplet Digital PCR.
    Lin B; Tian T; Lu Y; Liu D; Huang M; Zhu L; Zhu Z; Song Y; Yang C
    Angew Chem Int Ed Engl; 2021 Mar; 60(14):7582-7586. PubMed ID: 33382182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Detection of Exosomal PD-L1 in Peripheral Blood.
    Wang R; Yang Y; Huang J; Yao Y
    Methods Mol Biol; 2023; 2695():195-212. PubMed ID: 37450120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microfluidic strategies for separation and analysis of circulating exosomes].
    Chen W; Gan Z; Qin J
    Se Pu; 2021 Sep; 39(9):968-980. PubMed ID: 34486836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 exosomes electrochemical sensor based on coordination of AgNCs and Zr
    Hu J; Mao Z; Lu Y; Chen Q; Xia J; Deng H; Chen H
    Biosens Bioelectron; 2023 Sep; 235():115379. PubMed ID: 37207581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.